CIMIP2B and polycystic ovary syndrome: In conclusion, this study provides valuable insights into the common molecular mechanisms of PCOS and RSA, and highlights the potential of FAM166B as a diagnostic marker for PCOS and RSA, laying the foundation for targeted therapy and improving the fertility of PCOS patients.